Browsing: Wellness Tips

Popular GLP-1 weight loss drugs are now available to some Medicare enrollees for $50 a month under a new bridge program that launched July 1, marking the first time Medicare has covered any medication for weight loss

JAKARTA – Obesity is still often seen as a matter of appearance or numbers on the scales. In fact, this condition is a chronic metabolic disease that affects various aspects of women’s health

PILA PHARMA AB (publ) (FN STO: PILA), an innovative biotech company developing a novel oral drug based on TRPV1 inhibition for treatment of obesity and diabetes, announces that a share purchase agreement was made between entities controlled by Dorte X. Gram, Chairman of the Board of PILA PHARMA AB

USC research shows that a common genetic variant in Indigenous American populations silences the mitochondrial microprotein “MENTSH.” Restoring it improves insulin signaling and blocks diet-induced weight gain in preclinical studies

Plastic surgeons have warned against the rising trend of combining weight-loss drugs with supersized enhancements and other cosmetic techniques, saying they could pose serious long-term health problems

After years of strong growth, the obesity drug market is now slowing as businesses and health insurers cut back on coverage, signaling a more cautious phase

|| Interior view of Hanmi Pharmaceutical’s Pyeongtaek manufacturing center. Photo courtesy of Hanmi Pharmaceutical

Ariana Grande is trending on social media — not necessarily for her music, but for her appearance. A recent photo of the 33-year-old star posing with a young fan sparked a viral conversation on X (formerly Twitter) about the singer’s weight

OKLAHOMA CITY –A University of Oklahoma researcher is part of an international team developing a new way to discover obesity drugs using human cells instead of animal models, an approach that could speed the development of more effective and affordable treatments. The effort is supported by a $12 million grant from the Novo Nordisk Foundation

Viking Therapeutics VKTX reported a second-quarter 2026 loss of $1.10 per share, narrower than the Zacks Consensus Estimate of a loss of $1.21. The reported loss, however, widened from a loss of 58 cents per share in the year-ago quarter due to higher operating expenses